CN-3000/6000 Systems
Small-sized, mid- and high-volume hemostasis testing solutions to tackle big lab challenges.
The CN-3000 and CN-6000 Systems leverage optical testing methodology with intelligent software to automate and standardize sample management for reliable results, reduced repeat testing, and reagent waste. With the flexibility to support mid- or high-volume throughput needs, to operate as stand-alone analyzers, or connect to automation, the systems deliver what labs need to support a variety of testing profiles and space requirements.
- Smallest footprint available with rapid throughput enhances productivity per square meter.*
- Industry-leading throughput of up to 450 PT/APTT tests/hour†
- Smart workflow features help staff plan daily requirements and reduce interruptions.
- Sophisticated operating system detects potential issues before they become problems and guides troubleshooting.
- Integrated platelet aggregation testing‡,§ simplifies and automates assessment of platelet disorders.
- Advanced preanalytical sample quality (PSI) checks and smart sample management provide confidence in results.
- Streamlined security, maintenance, and user access enable operational efficiency.
- Single-discipline and multi-disciplinary automation is supported by Aptio Automation, FlexLab™, and other third party solutions.**
*As of January 2026. Footprint compared to competitor systems in the same volume class as listed on https://www.captodayonline.com/, https://www.trillium.de and sthemO 301 and sthemO 201 analyzer brochures, Stago, 2023.
†As of January 2026. Throughput evaluated against systems in the same volume class as listed on https://www.captodayonline.com/ and https://www.trillium.de. No throughput data available for sthemO 301 and sthemO 201 analyzers. CN-6000 System throughput: 450 PT/APTT; CN-3000 System throughput: 217 PT/APTT.
‡The products/features/applications mentioned here are not commercially available in all countries and are subject to local regulations. Their future availability cannot be guaranteed. Not available for sale in the U.S.
§HYPHEN BioMed reagent.
**Connects to Aptio Automation and to FlexLab™, FlexLab™ HT and FlexLab™ X. Several third-party connectivity options are available on request. Other third-party connectivity options are under development. Not available for sale. Future availability cannot be guaranteed.
Product availability may vary from country to country and is subject to varying regulatory requirements. Please contact your local representative for availability. FlexLab™ X is manufactured by Inpeco and distributed by Siemens Healthcare Diagnostics Inc. FlexLab is a trademark of Inpeco SA.
Product availability may vary from country to country and is subject to varying regulatory requirements. Please contact your local representative for availability. FlexLab™ HT is manufactured by Inpeco and distributed by Siemens Healthcare Diagnostics Inc. FlexLab is a trademark of Inpeco SA.
Aptio Automation is manufactured by Inpeco and is exclusively distributed by Siemens Healthcare Diagnostics Inc. Aptio is a trademark of Siemens Healthcare Diagnostics Inc. Inpeco is a trademark of Inpeco SA. Product availability may vary from country to country and is subject to varying regulatory requirements. Please contact your local representative for availability.
CN-3000 and CN-6000 Systems refer to Automated Blood Coagulation Analyzer CN-3000 and Automated Blood Coagulation Analyzer CN-6000 respectively. CN Systems refers to Automated Blood Coagulation Analyzer CN-3000 and Automated Blood Coagulation Analyzer CN-6000.
All other trademarks and brands are the property of their respective owners.
Product availability may vary from country to country and is subject to varying regulatory requirements. Please contact your local representative for availability.
What laboratories need to know as hemophilia gene therapy expands
After years of research, gene therapy is entering clinics worldwide, bringing new expectations and new responsibilities for diagnostic laboratories
Innovative anti-Xa assay sets new standard in anticoagulant diagnostics
The INNOVANCE Anti-Xa assay for anticoagulant therapy management delivers fully automated, ready-to-use testing for heparins, rivaroxaban, apixaban, and edoxaban



















